The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLuceco Regulatory News (LUCE)

Share Price Information for Luceco (LUCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.60
Bid: 158.60
Ask: 159.80
Change: 0.00 (0.00%)
Spread: 1.20 (0.757%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 159.60
LUCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Jul 2020 12:50

RNS Number : 2517T
Luceco PLC
16 July 2020
 

LUCECO PLC (THE "COMPANY")

GRANT OF AWARDS UNDER PERFORMANCE SHARE PLAN

 

The Company announces that awards have been granted to the following Persons Discharging Managerial Responsibility ("PDMRs") under the Luceco 2017 Performance Share Plan ("PSP"), which was approved by shareholders at the Company's AGM held on 25 May 2017.

 

Each of the following PDMRs has, on 14 July 2020, been granted awards in the form of nil-cost options over the number of ordinary shares of 0.05 pence in the Company under the terms of the PSP as set out below:

 

PDMR

Role

Number of shares subject to award

John Hornby

Chief Executive Officer

329,736

Matt Webb

Chief Financial Officer

282,631

Wayne Hill

Managing Director - Europe

103,631

David Nix

Director of Group Finance

87,144

James Hall

Corporate Development Director

85,750

 

In addition each PDMR has been awarded a linked tax qualifying option over 27,440 shares at an exercise price of £1.0933. On exercise the number of shares under the nil-cost option will be reduced proportionally to take account of any gain on the exercise of the tax qualifying option such that the PDMR will not receive a greater number of shares than is subject to the nil-cost option.

 

The awards will vest subject to continued employment and the satisfaction of performance conditions measuring the Company's earnings per share and total shareholder return performance. The extent to which awards will vest will depend on the extent to which the performance conditions are satisfied over the performance period, which runs from 1 January 2020 to 31 December 2022. No consideration was paid for any of the awards.

 

This notification is made under Article 19.1 and in accordance with Article 19.3 of the Market Abuse Regulation 2015.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. John Hornby

2. Matt Webb

3. Wayne Hill

4. David Nix

5. James Hall

2

Reason for the notification

a)

Position/status

1. PDMR

2. PDMR

3. PDMR

4. PDMR

5. PDMR

 

 

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Luceco PLC

b)

LEI

213800BBFZK4W4P98U76

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.0005 each

ISIN: GB00BZC0LP49

b)

Nature of transaction

Grant of awards in the form of nil-cost options over ordinary shares of 0.05 pence in the Company

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

 

1. 329,736

2. 282,631

3. 103,631

4. 87,144

5. 85,750

 

d)

Aggregated information

- Aggregated volume

- Price

 

 N/A (Single transaction)

e)

Date of the transaction

2020-07-14

f)

Place of the transaction

Outside a trading venue (XOFF)

 

ENDS

 

For further information contact Matt Webb, Chief Financial Officer 01952 238180

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBBGDRRSBDGGL
Date   Source Headline
5th Nov 202111:36 amRNSHolding(s) in Company
21st Oct 20217:00 amRNSQ3 Trading Update
14th Oct 20219:50 amRNSDirector Declaration and Board Committee Changes
13th Oct 20217:00 amRNSAcquisition of DW Windsor Group
1st Oct 20217:00 amRNSAnnouncement of new credit facilities
27th Sep 20215:21 pmRNSDirector/PDMR Shareholding
22nd Sep 20214:22 pmRNSDirector/PDMR Shareholding
17th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 202112:05 pmRNSReplacement: 2021 Interim Results
7th Sep 20217:00 amRNS2021 INTERIM RESULTS
12th Aug 20215:47 pmRNSDirector Declaration
9th Aug 20217:00 amRNSNotice of Results and Investor Presentation
5th Aug 20212:33 pmRNSHolding(s) in Company
3rd Aug 202110:31 amRNSHolding(s) in Company
16th Jul 20215:16 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSFirst half trading update
9th Jul 202110:06 amRNSHolding(s) in Company
25th Jun 20212:46 pmRNSHolding(s) in Company
8th Jun 202110:18 amRNSHolding(s) in Company
8th Jun 202110:15 amRNSHolding(s) in Company
7th Jun 20212:35 pmRNSDirector/PDMR Shareholding
7th Jun 202112:23 pmRNSHolding(s) in Company
26th May 20215:35 pmRNSHolding(s) in Company
13th May 20213:44 pmRNSResult of AGM
13th May 20217:00 amRNS2021 AGM Trading Update
5th May 20211:59 pmRNSDirector/PDMR Shareholding
29th Mar 202110:08 amRNSDirector/PDMR Shareholding
24th Mar 20213:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:10 pmRNSHolding(s) in Company
23rd Mar 20212:40 pmRNSEmployee Benefit Trust Share Purchase
23rd Mar 20217:00 amRNS2020 Full Year Results
19th Feb 20216:04 pmRNSHolding(s) in Company
19th Feb 20216:02 pmRNSHolding(s) in Company
19th Feb 20216:00 pmRNSHolding(s) in Company
18th Feb 20215:38 pmRNSDirector/PDMR Shareholding
17th Feb 20214:32 pmRNSDirector/PDMR Shareholding
17th Feb 20214:30 pmRNSDirector/PDMR Shareholding
16th Feb 20212:55 pmRNSEmployee Benefit Trust Share Purchase
9th Feb 20211:34 pmRNSEmployee Benefit Trust Share Purchase
4th Feb 20214:30 pmRNSDirector/PDMR Shareholding
1st Feb 202111:35 amRNSEmployee Benefit Trust Share Purchase
28th Jan 20215:19 pmRNSDirector Declaration
25th Jan 20213:32 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSFY 2020 Trading Update and Notice of Results
11th Jan 20215:21 pmRNSEmployee Benefit Trust Share Purchase
18th Dec 202010:01 amRNSHolding(s) in Company
15th Dec 20202:29 pmRNSHolding(s) in Company
18th Nov 202010:24 amRNSDirector/PDMR Shareholding
18th Nov 202010:22 amRNSHolding(s) in Company
6th Nov 20204:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.